الصفحة الرئيسية>>Lipids>> Sphingolipids>>1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))

1-β-D-Glucosylsphingadienine (d18:2 (4E,8E)) (Synonyms: Glucosylsphingadienine (d18:2 (4E,8E)), 1-β-D-Glucosylsphingadienine (plant), Glucosylsphingosine (plant))

رقم الكتالوجGC42050

1-β؛ -D-Glucosylsphingadienine (d18: 2 (4E، 8E)) هو جلوكوزيل سفينغوزين ، وهو مشتقات ليسوليبيد منزوعة الأستيل من جلوكوزيل سيريبروسيدات.

Products are for research use only. Not for human use. We do not sell to patients.

1-β-D-Glucosylsphingadienine (d18:2 (4E,8E)) التركيب الكيميائي

Cas No.: 114200-59-8

الحجم السعر المخزون الكميّة
500μg
153٫00
متوفر
1mg
274٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

1-β-D-Glucosylsphingadienine is a glucosylsphingosine, which are deacetylated lysolipid derivatives of glucosylcerebrosides . They are formed when sphingosines undergo glucosidation by UDP-glucose. Glucosylsphingosines completely reduce neurite outgrowth and induce death of LA-N-2 cells at concentrations of 10 and 50 μM, respectively. They also decrease the activity of glucocerebrosidase in LA-N-2 cells in a dose-dependent manner. Glucosylsphingosine levels are elevated in patients with Gaucher's disease, both in the spleen (in types 1, 2, and 3) and brain (type 2 and 3); thus, glucosylsphingosine has been used as a key biomarker of the disease. This product contains 1-β-D-glucosylsphingadienine isolated from plants.

مراجعات

Review for 1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.